CLINICAL_TRIALS
trial_result
· 2018-01-24
Clinical Trial Update: 12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device [Phase 3]
Summary
Phase 3 trial update for intranasal fluticasone propionate (OptiNose device) in nasal polyps completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Optinose US Inc. | Conditions: Nasal Polyps | Phase 3 | Status: COMPLETED | Results posted: 2018-01-24